At least got growth and increase in profit. Now in KLSE ,at least 95% show reducing profit or huge losses or facing cash flow problems but Scommet expect next quarter will be better.
Big fund may be the one who push the price up and when they see many ikan bilis follow they may start to throw out their tickets. Trap or real share price up?
Honestly speaking this qr is good but underwhelming for me especially for the current price. Hopefully next qr would be better bit I wonder if its priced in already
Supercomnet hits record high as orders from medical device makers soar -A+A Supercomnet’s main customers comprise New York Stock Exchange-listed Edwards Lifesciences Corp and Denmark-based Ambu, both of which have signed long-term agreements with the company.
KUALA LUMPUR (June 17): Shares in Supercomnet Technologies Bhd, which specialises in making wires and cables for medical devices, soared to a record high of RM1.33 in the morning session today.
At noon break, the stock had surged 26.2% or 27 sen to RM1.30. Its trading volume swelled to 38.07 million shares, substantially higher than its 200-day average trading volume of 1.95 million shares.
The Edge Malaysia weekly previously reported that Supercomnet’s wholly-owned subsidiary Supercomal Medical Products Sdn Bhd (SMP), which manufactures cables used to connect various medical devices, had seen order volume double since the Covid-19 outbreak began.
“Demand for medical cables has always been strong, but recent orders from our clients indicate that demand is picking up even further,” said Supercomnet managing director James Shiue Jong-Zone in an interview with The Edge.
The main products developed by the company include disposable medical consumables for Class 1, Class 2 and intensive care unit (ICU) usage.
Supercomnet’s main customers comprise New York Stock Exchange-listed Edwards Lifesciences Corp and Denmark-based Ambu, both of which have signed long-term agreements with the company.
Shiue highlighted that the group had been in business with its clients for more than 10 years and, on average, orders increased by 5% to 10% every year, whether or not there was a recession.
Supercomnet recorded a 55% year-on-year (y-o-y) jump in net profit to RM18.82 million for the financial year ended Dec 31, 2019 (FY19), mostly driven by its unit SMP, which is deemed the jewel in the group’s crown. Revenue grew 39% y-o-y to RM122.97 million. It will report its March quarter results for FY20 this month.
The medical device segment has been the driver of the group’s growth over the last three years, a situation Shiue does not see changing anytime soon.
The revenue contribution from the medical device segment is predicted to surpass that of the automotive segment for the first time this year from a 50:50 share in FY19.
Of the group’s immediate plans, Shiue said Supercomnet will put all its efforts into delivering orders to its clients, and it had allocated capital expenditure of about RM7 million to RM8 million for FY20.
Read also: Supercomnet Technologies wired to medical device market growth
This is Jan-Mar quarter result. Pandemic surge mid March onwards. Next quarter result will reflect April-June. Scomnet price starts to surge at end May and mid June, does it mean Q2 results going to be much better? If stock price is forward looking, then objectively Q2 result should be very good. Does it mean the big funds that entered in Mid June are already looking forward to and anticipate the next good quarter result?
This is still a fundamentally strong company. The only question that remains is if it is overvalued or fair value. I will certainly hold some of the mother shares.
I hope that some of you remain objective and not only hear selective good stuff about a company. That is how a safe investor should be anyway.
I am still holding from 80 cent ... drop will add coz me too already sell 2 times ... results ok ma.... true sold Liao diam diam don’t talk here talk there...congrats to those take profit ... those still holding sure will get reward later... must hav holding power...
From glove forum untill healtcare stock ... all sound high pe, overpriced , burst here burst there... but they still vry steady at their price till now ... will hold till next year... Kecuali crisis 1 more time or else all this counter fundamentals and their sales high demand
Just learn from sohai Philip and sohai 3iii, just look at the Pe of QL and Nestle all above 50x....they still say undervalue bcos of growth & stability of earnings mah....!!
This can be further justify with low rate of return of bank deposits which at the moment about 2% pa fixed return which offer no growth opportunity loh...!!
Honestly again its normal, not fantastic. But with the fundamental of the company, its strong. No gearings, their two major clients are strong. Edward Lifescience SPIEN 3 THV is cleared for use in CHINA. Their current QR is reflecting Jan to Mar. This year their earning picked up in May. So the next QR, which might come out around August or Sept, will surely be strong. So either you hold or sell, there's no right or wrong to it. Daily traders will say i am deceiving myself. But as an investor this is what I look forward to, the long run.
During MCO every company is effected, this company is strong and steady, what do you expect during lockdown can anyone do wonder, this qtr is consider good, next qtr is great, will hold on to it..
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
monique1968
252 posts
Posted by monique1968 > 2020-06-24 22:41 | Report Abuse
Beautiful chart